Erwin Waldvogel

Title: Erwin Waldvogel: Innovator in Pharmaceutical Chemistry

Introduction

Erwin Waldvogel is a notable inventor based in Aesch, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work focuses on the development of processes for producing various chemical compounds with high purity and efficacy.

Latest Patents

Waldvogel's latest patents include a process for the production of substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives. This invention relates to a new method for producing these derivatives, particularly 2-[2-(3-butoxyphenyl)-ethylamino]-N,N-dimethylacetamide, in high yields with very high chemical purity. Another significant patent involves the production of ralfinamide salts that are substantially free from impurities with genotoxic effects. This process ensures high yields and purity of the compound (S)-2-[4-(2-fluorobenzyloxy) benzylamino]propanamide, or ralfinamide, in the form of a crystalline anhydrous polymorph identified as form A.

Career Highlights

Throughout his career, Waldvogel has worked with prominent companies in the pharmaceutical industry, including Sandoz GmbH and Newron Pharmaceuticals S.p.A. His expertise in chemical processes has made him a valuable asset in these organizations.

Collaborations

Waldvogel has collaborated with notable colleagues such as Gustav Schwarb and Jean-Pierre Bourquin. These partnerships have contributed to the advancement of his research and innovations in the field.

Conclusion

Erwin Waldvogel's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future innovations.